Cardiovascular Drugs Flashcards
Any drug or agent that affects the function of the heart and circulatory system, specifically blood vessels.
Cardiovascular Drugs
Affects heart and blood vessels.
● Anti-arrhythmic Drugs
● Beta-adrenergic Blockers
● Vasodilators
● Clonidine and Related Drugs
occur once the atria are filled with blood
P wave
came from firing of signals from the SA node
P wave
Time peaks for the signal to travel from SA node to AV node.
PR interval
Firing of AV node.
QRS complex
Aka ventricular depolarization
QRS complex
aka Atrial depolarization
P wave
Last phase of ventricular depolarization
S wave
Aka Plateau (due to its flat area)
ST segment
aka ventricular repolarization
T wave
Opening of Na channel causing Na influx
PHASE 0
Aka Rapid depolarization phase
PHASE 0
Early fast repolarization
PHASE 1
Closure of Na channel; opening of K and Cl channel
PHASE 1
Sustained balance between inward movement of Ca (influx) and outward movement of potassium (efflux)
PHASE 2
Ca channel opens and K channel remain open
PHASE 2
Rapid repolarization
PHASE 3
Ca channel closes, but K channel continues to be opened.
PHASE 3
Diastole or resting state
PHASE 4
Plateau
PHASE 2
Interfere with Na channel (affect the Phase 0 by decreasing this)
Sodium channel blockers
All channels close
PHASE 4
Class I – Na+ Channel Blockers block what phase?
Phase 0
Class III – K+ Channel blockers block what phase?
Phase 2 & 3
Class IV – Ca++ Channel blockers block what phase?
Phase 2
Aka Membrane stabilizing agent
Type I anti-arrhythmic drugs
Phase of action potential that can cause homeostasis
PHASE 2
Generally act by inhibiting fast sodium channels responsible for initial cardiac cell depolarization and impulse conduction.
Type I anti-arrhythmic drugs
In overdose, all Type I drugs have the potential to markedly depress
myocardial automaticity, conduction, and contractility
Class Ia
✓ Disopyramide
✓ Quinidine
✓ Procainamide
Class Ib
✓ Lidocaine
✓ Mexeletine
✓ Tocainide
Class Ic
✓ Moricizine
✓ Flecainide
✓ Propefanone
Depress the FAST sodium dependent channel, slowing phase zero of the cardiac action potential.
Class Ia agents
Prolong Action Potential Duration
Class Ia
Diastereoisomer of Quinine
Quinidine
Quinidine moa
● sodium channel blocker
● alpha receptor blocker
● anticholinergic action
Adr of Quinidine
Cinchonism
An N-metabolite, which is a highly reactive metabolite
Procainamide (Pronestyl®)
Procainamide moa
sodium channel blocker, neuromuscular blocker
Adr of Procainamide
GI upset, SLE-like symptoms
Disopyramide (Norpace®) is a vagolytic causing (CUD)
urinary retention, constipation, and dry mouth
Commonly used for suppression of acute and chronic supraventricular and ventricular arrhythmias
Quinidine and procainamide
has ganglionic-and neuromuscular-blocking activity
Procainamide
has alpha-adrenergic receptor blocking activity
Quinidine
Toxic dose of Quinidine
1 g
Toxic dose of Procainamide
5 g
Toxic dose of Disopyramide
1 g
Quinidine and disopyramide (both are anticholinergic) can cause:
Dry mouth
Dilated pupils (Mydriasis)
Delirium
Flushed skin
All type Ia agents can produce
● Seizures
● Coma
● Respiratory arrest
Cinchonism
tinnitus, vertigo, deafness, visual disturbances
indicated for patients unresponsive to sodium bicarbonate therapy
Cardiac pacemaker
Active metabolite of procainamide
N-Acetylprocainamide (NAPA)
Weak sodium channel blocking ability
Class Ib
Analog of lidocaine
Tocainide
Adr of Tocainide
GIT upset, Paresthesia, Tremor, Ataxia
A congener of lidocaine that is resistant to first pass hepatic metabolism.
Mexiletine
Adr of Mexiletine
Ataxia, Blurry vision
an aminoacyl amide synthetic derivative of cocaine
Lidocaine
It is an antidysrhythmic and local anesthetic agent
Lidocaine
Lidocaine (Xylocaine) is metabolized to two active metabolites
monoethyl glycine xylidide (MEGX) and glycine xylidide (GX)
Strong sodium channel blocking ability but no effect on action potential
Class Ic
Both sodium and potassium channel blocking effect.
Flecainide
was withdrawn from US and Canadian markets in Dec of 1991 due to increased mortality in the cardiac dysrhythmia trial
Encainide
analogue of lysergic acid, is at least 10 times more potent than procainamide.
Encainide
Fatal adr of Encainide
cardiac dysrhythmia
related to propranolol
Propafenone
Common adr of Class Ic drugs
● Dizziness
● Blurred vision
● Ventricular arrhythmias
Overdose of Class Ib may cause:
● sedation
● confusion
● coma
● seizures
● respiratory arrest
● cardiactoxicity
TOCAINIDE AND MEXILETINE Side effects may include:
● Dizziness
● Paresthesias
● Tremor
● Ataxia
● GIT disturbance
FLECAINIDE, ENCAINIDE, PROPAFENONE, MORICIZINE Side effects
● Dizziness
● Blurred vision
● Headache
● GIT upset
● Ventricular arrhythmias
Overdose of Class Ic causes:
● Hypotension
● Bradycardia
● AV block
● Asystole
● QRS and QT intervals are prolonged
Widely used for the treatment of hypertension, angina pectoris, migraine headaches, and glaucoma
Type II anti-arrhythmic drugs or Beta-adrenergic blockers
Repolarization is also delayed, resulting in a prolonged QT interval that may be associated with ______________
polymorphic ventricular tachycardia
Selective Beta-blockers (BEAM)
Betaxolol, Bisoprolol, Esmolol, Acebutolol, Atenolol, Metoprolol
Beta-blockers with Membrane Stabilizing Activity (anesthetic-like effect) (PALM)
Propranolol, Pindolol, Acebutolol, Labetalol, Metoprolol